adenosine monophosphate has been researched along with Bacteremia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Barsic, B; Bistrovic, P; Busic, N; Cesar, N; Cikara, T; Koscak, V; Lackovic, M; Lucijanic, M; Lucijanic, T; Mitrovic, J; Ortner Hadziabdic, M; Papic, I | 1 |
| Copaescu, A; Drewett, G; Gordon, CL; Holmes, NE; James, F; Mouhtouris, E; Smibert, OC; Trubiano, JA; Vogrin, S | 1 |
| Asimakis, GK; Chinkes, DL; Gore, DC; Hart, DW; Rinehart, AJ | 1 |
3 other study(ies) available for adenosine monophosphate and Bacteremia
| Article | Year |
|---|---|
Remdesivir use in COVID-19 patients might predispose bacteremia, matched case-control analysis.
Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Bacteremia; COVID-19 Drug Treatment; Humans | 2022 |
The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.
Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Anti-Inflammatory Agents; Antiviral Agents; Bacteremia; Biomarkers; C-Reactive Protein; Cohort Studies; Comorbidity; COVID-19; COVID-19 Drug Treatment; Dexamethasone; Female; Humans; Interleukin-6; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Respiratory Distress Syndrome; Severity of Illness Index; Staphylococcal Infections | 2021 |
Sepsis-induced failure of hepatic energy metabolism.
Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Animals; Bacteremia; Blood Flow Velocity; Blood Pressure; Energy Metabolism; Hepatic Artery; Hepatic Veins; Infusions, Intravenous; Lactic Acid; Liver; Male; NAD; Oxygen; Oxygen Consumption; Phosphorylation; Portal Vein; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Shock, Septic; Swine | 2003 |